The first bioengineered, autologous, dermo-epidermal skin grafts are presently undergoing clinical trials; hence, it is reasonable to envisage the next clinical step at the forefront of plastic and burn surgery, which is the generation of autologous skin grafts that contain vascular plexuses, preformed in vitro. As the importance of the blood, and particularly the lymphatic vascular system, is increasingly recognized, it is attractive to engineer both human blood and lymphatic vessels in one tissue or organ graft. We show here that functional lymphatic capillaries can be generated using three-dimensional hydrogels. Like normal lymphatics, these capillaries branch, form lumen, and take up fluid in vitro and in vivo after transplantation onto immunocompromised rodents. Formation of lymphatic capillaries could be modulated by both lymphangiogenic and anti-lymphangiogenic stimuli, demonstrating the potential usefulness of this system for in vitro testing. Blood and lymphatic endothelial cells never intermixed during vessel development, nor did blood and lymphatic capillaries anastomose under the described circumstances. After transplantation of the engineered grafts, the human lymphatic capillaries anastomosed to the nude rat's lymphatic plexus and supported fluid drainage. Successful preclinical results suggest that these skin grafts could be applied on patients suffering from severe skin defects.
INTRODUCTION
The critical importance of the lymphatic system in the human body becomes increasingly evident. Consequently, the tissue engineering of lymphatic organs (lymphatic vessels, lymph nodes, spleens, and cells derived from lymphatic organs) not only generates valuable ex vivo research models but also allows the transplantation of these organs to repair or improve lymphatic deficiencies caused by disease or injury (1) .
Our research focuses on the bioengineering of full-thickness skin analogs: dermo-epidermal skin substitutes with physiological, structural, and functional properties (2) . A central issue of this approach is the in vitro generation of a preexisting network of capillaries (3) , which significantly supports perfusion of the dermal component, hence, providing rapid and efficient access to oxygen and nutrients, which assures rapid take, proliferation, and differentiation of the skin transplant (2) . Prevascularized dermo-epidermal skin substitutes were generated using primary human endothelial cells and sophisticated biological matrices (4) (5) (6) (7) . So far, however, limited data are available on the bioengineering of functional human lymphatic capillaries or on the integration of a dermal lymphatic network in skin grafts.
In the human dermis, lymphatic vessels play a major role in tissue fluid homeostasis and immune cell trafficking (8) . Dermal lymphatic capillaries exhibit a wide lumen, anchoring filaments, and no or an incomplete basement membrane, and lack mural cell coverage. These features enable lymphatic capillaries to respond to interstitial liquid pressure by taking up and removing excess tissue fluid (8, 9) . After wounding, also the lymphatic endothelium is ruptured; thus, the draining capacity of the lymphatic vessels is compromised. As a consequence, accumulation of tissue fluid, that is, lymphedema, seroma, or lymphoceles (10) (11) (12) , arises. Persistent local interstitial fluid, as well as delayed removal of local debris and inflammatory cells, impedes wound healing. In contrast, induction of lymphangiogenesis and immune cell recruitment were shown to accelerate skin regeneration (13) . Therefore, to achieve a physiologically relevant dermal tissue complexity, and accelerate skin tissue regeneration after graft transplantation, a skin graft containing both blood and lymphatic vessels would ideally serve to efficiently reconstitute a full-thickness skin defect.
This study demonstrates the in vitro bioengineering and in vivo grafting of a human dermo-epidermal skin substitute prevascularized by both lymphatic and blood capillaries. Both the pure population of human lymphatic endothelial cells (hLECs; isolated from human foreskin) and the hLEC fraction present in human dermal microvascular endothelial cells (HDMECs; isolated from human foreskin) developed into lumenforming bona fide lymphatic capillaries in vitro within 21 days in either fibrin or collagen type I hydrogels. We confirmed the lymphatic nature of the engineered microvessels by showing that they presented anchoring filaments, expressed all major lymphatic markers, and could be modulated by both lymphangiogenic and anti-lymphangiogenic stimuli.
Lymphatic functionality was confirmed by demonstrating that the bioengineered lymphatic microvessels took up fluid from the interstitial space in vitro and triggered fluid drainage in vivo. Grafting studies in vivo revealed that the engineered lymphatic microvessels maintained their lumens as well as their typical characteristics, such as the absence of a complete basement membrane and the lack of mural cell coverage. We found that bioengineered human lymphatics anastomosed to the recipient's lymphatics as early as 14 days after transplantation. When transplanted onto immunoincompetent rats, the prevascularized dermis supported the development of the epidermis, indicating that it may, in the future, be possible to translate these prevascularized dermo-epidermal substitutes into clinical application.
RESULTS
Bioengineering of human lumen-forming lymphatic capillaries in three-dimensional hydrogels in vitro The identification of markers specific for the lymphatic vascular lineage has made it possible to isolate hLECs at high purity from human dermis by either fluorescence-activated cell sorting (FACS) or magneticactivated cell sorting (14) . Prox1, a marker of human lymphatic vessels (15, 16) , was homogeneously expressed by hLECs in conventional cell culture (Fig. 1A) . Confluent hLEC monolayers assembled into cord-like structures when overlaid with collagen type I gels for up to 20 hours in vitro (Fig. 1B) . These cords, often referred to as tube-like structures in a tube formation assay, are somehow reminiscent of the morphology of microvessels. However, under these in vitro circumstances, lumen formation did not occur (Fig. 1B) .
Using a method that we had established previously for HDMECs (7), we investigated whether hLECs would similarly arrange into lumen-forming true capillaries in both fibrin and type I collagen hydrogel; indeed, hLECs developed into branching capillaries (Fig. 1 , C, D, and F), as revealed by staining for CD31-a pan-endothelial cell marker-3 weeks after coculture with 40% human dermal fibroblasts. Notably, capillary formation did not occur in the absence of fibroblasts ( Fig. 1, E and F) . Likewise, neither fibroblast-conditioned medium, the addition of vascular endothelial growth factor-A (VEGF-A) or VEGF-C, nor the presence of fibroblasts on the underside of a Transwell system induced capillary formation in hLECs (Fig. 1F) . Hence, the physical contact between human dermal fibroblasts and LECs was a requisite for the development of true branching lymphatic capillaries in the hydrogel. Histology revealed that the engineered capillaries developed a continuous lumen of physiological size (17 to 60 mm) (Fig. 1G) , with an average lumen diameter of 28 + 10.67 mm (+SEM, 25 lymphatic vessels analyzed per five hydrogels) measured on whole-mount specimens.
The lymphatic nature of the capillaries was confirmed by double immunofluorescence staining performed on whole-mount hydrogel preparations. The bioengineered lymphatic capillaries expressed CD31 ( Fig. 2A) and the lymphatic-specific nuclear transcription factor Prox1 (Fig. 2, A to D) . Most of the capillaries showed a physiological size (10 mm in diameter) (17) of the nuclei (Fig. 2B) . Two other lymphatic vascular markers, Lyve-1 (Fig. 2C) and podoplanin ( Fig. 2D) , confirmed the lymphatic nature of the bioengineered human capillaries.
Modulation of capillary formation by pro-and anti-lymphangiogenic stimuli in vitro To investigate whether lymphatic vessel formation in vitro is modulated by known lymphangiogenic and anti-lymphangiogenic stimuli, Fig. 1 . hLECs develop into lumen-forming lymphatic capillaries in hydrogels in vitro. (A) hLECs express Prox1 + (green). Scale bar, 50 mm. (B) hLECs assemble into cords in a 2D tube formation assay. Scale bar, 25 mm. (C to E) Whole-mount CD31 immunofluorescence analysis reveals that hLECs develop into capillaries when cocultured with human fibroblasts in either fibrin (C) or collagen (D) hydrogels, but not in the absence of human fibroblasts (E). Scale bars, 50 mm. (F) hLECs cultured in fibrin with 0 to 40% fibroblasts (Fibs), fibroblasts in a Transwell system (TW), human dermal fibroblasts-conditioned medium (C-Medium), VEGF-A, or VEGF-C. Data are means ± SEM (n = 6 hydrogels per group). *P < 0.05, ***P < 0.001, versus 0% fibroblasts using t test. ns, not significant. (G) Immunofluorescence analysis for CD31 (red) on paraffin sections shows lumen formation in lymphatic capillaries. Cell nuclei stained with 4′,6-diamidino-2-phenylindole (DAPI) (blue). Images are representative of n = 18 hydrogels. Scale bar, 10 mm (inset, 50 mm).
we investigated the effect of pro-lymphangiogenic VEGF-A and VEGF-C, as well as the effect of anti-lymphangiogenic transforming growth factor-b1 (TGF-b1) and the tyrosine kinase inhibitor SU5416 (18) . Both VEGF-A and VEGF-C significantly promoted the formation of lymphatic capillaries in vitro compared to the factor-free control medium (Fig. 3 , A to C and F). In contrast, exposure to SU5416 led to a significant inhibition of vessel formation (Fig. 3, D and F) . Likewise, treatment with TGF-b1 significantly inhibited the formation of lymphatic microvessels (Fig. 3, E and F) . Further analysis showed that hLECs tended to assemble into a slightly higher number of capillaries in type I collagen hydrogels compared to fibrin hydrogels in the presence or absence of VEGF-C (Fig. 3F) . However, differences were not statistically significant.
Isolation of single-cell suspension from lymph-vascularized hydrogels Studies on lymphatic vessel formation might necessitate specific molecular analysis at a cellular level to narrow down molecular pathways involved in lymphangiogenesis. Hence, we next investigated the possibility of retrieving single human cells from the lymph-vascularized hydrogels for further studies (Fig. 4A) . Three weeks after in vitro culture, hLECs had assembled into CD31 + /Prox1
+ lymphatic capillaries as in Fig. 1D . At this stage, type I collagen hydrogels were digested using collagenase type II, and single cells were isolated and FACS-sorted into CD31 + / CD90
− hLECs and CD31 − /CD90 + fibroblasts (Fig. 4 , B and C). After sorting, the individual populations of hydrogel-derived hLECs and fibroblasts were used to develop new lymph-vascularized hydrogels. The isolation/sorting procedure neither impaired the formation of the capillaries nor affected their lymphatic nature, as confirmed by whole-mount immunofluorescence staining for CD31 and Prox1 (Fig. 4, D 
and E).
Bioengineering a composite blood/ lymphatic vascular plexus On the basis of our ability to bioengineer blood capillaries and lymphatic capillaries in vitro, we focused on the generation of a complete dermal vascular plexus for skin grafting. This was achieved by coculturing HDMECs, isolated from human foreskin, in three-dimensional (3D) fibrin hydrogels. HDMECs consist of a mixture of both hLECs and human blood vascular endothelial cells (hBECs), as confirmed by a staining for Prox1 (Prox1 + hLECs and Prox1 − hBECs) (Fig. 5A ). Coculture of HDMECs and human dermal fibroblasts in fibrin hydrogels for 3 weeks resulted in the formation of branching, lumenized capillaries (Fig. 5, B + blood capillaries were present in these hydrogels (Fig. 5D ). In addition to Prox1, the two types of capillaries could also be discriminated using Lyve-1 (Fig. 5E ). The two distinct types of microvessels were never found to anastomose in vitro; that is, they never formed hybrid blood-lymph capillaries. Similar to the hLEC cultures, HDMECs developed into lumen-forming capillaries in both fibrin (Fig. 5D ) and collagen type I hydrogels (Fig. 5F ).
To further investigate the functionality of the bioengineered lymphatic vessels, we determined whether the capillaries would react to interstitial pressure variations and resolve tissue fluid accumulation. Evans blue dye (20 to 80 ml) was injected into prevascularized hydrogels (Fig. 5G ). After injection, CD31
+ and Lyve-1 + lymphatic capillaries were found to take up the dye from the extracellular space (Fig. 5H) . Figure 5G shows that the area surrounding the lymphatic vessels was cleared from the dye after 20 minutes. These results show that the engineering of a dermal vascular plexus containing both blood and lymphatic capillaries is achievable and that the lymphatic capillaries exhibit their specific function, which is the uptake and removal of tissue liquid.
Human blood and lymphatic vascular plexus in bioengineered dermo-epidermal skin substitutes and in vivo grafting Toward translation, we next monitored the transplantation of human dermo-epidermal skin grafts containing a composite vascular (blood and lymph) plexus onto rats. First, skin grafts were created in vitro using CD31 + HDMECs, human CD90 + fibroblasts, and human keratin5 + (K5 + ) keratinocytes in fibrin hydrogels. Figure 6A shows a confocal micrograph of a capillary (red) surrounded by fibroblasts (blue) in a fibrin hydrogel. Both cell types constituting the dermal compartment of the graft were arranged underneath several layers of keratinocytes (green), the epidermal compartment. These skin grafts were then transplanted onto wounded backs of immunoincompetent nu/nu rats using a Fusenig chamber to avoid competitive, lateral ingrowth/ overgrowth of rat keratinocytes (Fig. 6B ). The circular patch of the thin human epidermis was macroscopically visible. Two weeks after transplantation, the human skin substitute was surgically removed from the rat underlying tissue and analyzed for dermal structure and neovascularization. The vascularized neodermis supported stratification of the overlaying epidermis (Fig. 6C ).
Immunofluorescence analysis after 2 weeks revealed the presence of both human blood and lymphatic microvessels in the neodermis ( + lymphatic microvessels maintained their lumen in vivo (Fig. 6D, asterisks) . Human microvessels expressing Lyve-1 and podoplanin were detected, indicating that human lymphatic capillaries remained intact 2 weeks after transplantation (Fig. 6E , arrow, and F to H). Blood microvessels that solely expressed CD31 were also detected (Fig. 6E , arrowhead). Notably, the two distinct types of microvessels were never found to anastomose. Podoplanin + lymphatic capillaries did not stain for laminin1,2 ( Fig. 6F , arrow) but partially stained for collagen IV (Fig. 6G , arrows). Our analyses of mural cell (vascular smooth muscle cells and pericytes) coverage confirmed that the bioengineered human lymphatic capillaries were devoid of a-smooth muscle actin (aSMA)-expressing cells (Fig. 6H, arrows) .
Further analysis of the capillary revealed that podoplanin + human lymphatic microvessels presented fibrillin + anchoring filaments (Fig. 6I, arrows) . The presence of anchoring filaments strongly suggests that the capillaries could react to interstitial pressure variations and resolve tissue fluid accumulation in vivo. The presence of anchoring filaments and no or discontinuous basement membrane as well as the absence of mural cell coverage are major characteristics of lymphatic microvessels (8). Exposure to SU5614 or TGF-b1 inhibits the formation of human lymphatic microvessels. Scale bars, 50 mm (C and E) and 20 mm (B and D). (F) The density of the lymphatic capillaries was quantified. Data are means ± SEM (n = 6 hydrogels per group). **P < 0.01, ***P < 0.001 versus control fibrin hydrogels, unless otherwise indicated; ## P < 0.001 versus control collagen hydrogels, t test. All P values were calculated against the respective control, unless otherwise specified. All images are displayed as Z-stack confocal captions; grid defines the 3D space.
Anastomosis of bioengineered human lymphatic capillaries and in vivo functionality Bioengineered blood vessels have been shown to connect to the host blood vasculature after in vivo grafting (19) . We set out to investigate whether bioengineered lymphatic capillaries would also anastomose to the lymphatic vascular plexus of immunoincompetent recipient rats. The hydrogels were grafted to the wounded backs of nu/nu rats as in Fig. 6B . Immunofluorescence analyses of the expression of humanand rat-specific podoplanin showed that the human lymphatic capillaries, present in the bioengineered human dermis, connected to the host rat lymphatic vessels (3.5 + 2.6 SD anastomoses within a 0.5-mm stretch of bioengineered skin, total n = 8 animals) as early as 14 days after grafting (Fig. 7, A and B) .
Hybrid anastomosis between human lymphatic capillaries and rat blood capillaries was never observed. We found two types of anastomoses among human and rat lymphatics: a direct connection type (Fig. 7A , arrow in inset) and a wrapping connection type (Fig. 7B, arrowheads in  inset) . The direct connection appeared to occur by linking of the blunt ends of a human and a rat lymphatic capillary. In the wrapping connection, the human and rat LECs wrapped around each other to form a hybrid vessel (Fig. 7B) . Notably, rat lymphatics were found in close proximity to human lymphatic microvessels rather than randomly throughout the tissue (Fig. 7B) .
To investigate whether the bioengineered lymphatic capillaries would be functional in vivo, we performed lymphatic drainage experiments by injecting small amounts (25 ml) of Evans blue into grafts 15 days after transplantation. When analyzing the grafts 30 minutes after injection, about five fold more Evans blue was retained in the hydrogels containing human fibroblasts only (Fig. 7C ) compared with hydrogels containing human lymphatic and blood capillaries (Fig. 7, D and E), indicating lymphatic drainage function in the prevascularized grafts. These data suggest that the grafted human lymphatics were recognized by and anastomosed to the recipient's lymphatics and that the newly developed lymphatic plexus efficiently drained fluid in vivo.
DISCUSSION
Although structurally distinct, the blood and lymphatic vascular systems are functionally closely interconnected to ensure fluid and protein balance, cell nutrition, and immunologic functioning in tissues. The main function of the lymphatic system is the absorption of fluid and proteins that escaped from the blood circulation, hence, returning them back into the bloodstream. Impairment of lymphatic function leads to a number of diseases that are characterized by edema, seroma, lymphoceles, impaired immunity, and fibrosis (8) . As the critical importance of the lymphatic system in the human body becomes more evident, tissue engineers are getting increasingly motivated to generate both blood and lymphatic vessels, side by side in bioengineered tissue and organ grafts (20) .
Skin grafting is applied to treat defects caused by accident, such as burns, or in elective cases, such as scar revisions and removal of congenital nevi, or to treat chronic ulcers. Skin grafts may fail because of the development of infections, insufficient vascularization, hematoma, or seroma. Seromas occur by the accumulation of serous fluid underneath the graft because of the lack of sufficient drainage by the lymphatic system (21, 22) . Bioengineering a preformed network of lymphatic capillaries into dermo-epidermal skin grafts should help circumvent seroma formation by improving lymphatic drainage and accelerating the establishment of tissue fluid homeostasis.
In contrast to the large body of work done on the generation of blood vessels, only few studies have focused on engineering human lymphatic vasculature (23, 24) , including using a constant interstitial flow exerted by a bioreactor (25) (26) (27) . The use of bioreactors is technically demanding, and, although it certainly represents a valid in vitro test system, no data are yet available on such engineered capillaries in vivo. A second pilot approach to tissueengineered lymphatics indicated that hLECs could serve as seed cells to be combined with poly(glycolic acid) scaffolds (28) . The developed tissue-engineered tubular structures showed very preliminary characteristics of a lymphangion (3-mm diameter); however, lymphatic capillaries, 10 to 60 mm in diameter (29) , are required to constitute a functional, liquid-collecting, lymphatic plexus. The bioengineered lymphatic capillaries described herein showed exactly this range in diameter.
Our goal was to develop permanent, autologous dermo-epidermal skin grafts for clinical use. There are bioengineered grafts containing autologous keratinocytes and fibroblasts that are close to the clinical application, yet they are still not prevascularized (30) (31) (32) (33) (34) (35) (36) . Here, we show that it is possible to even go beyond this approach by undertaking the bioengineering of prevascularized skin grafts that contain a blood and a lymphatic plexus in the dermal compartment. Successful bioengineering of lumen-forming lymphatic capillaries is owed to the coculture of fibroblasts with the endothelium because hLECs alone did not develop into lymphatic capillaries. Fibroblasts are known to rapidly migrate into wound sites to establish an extracellular matrix that supports dermal vascular repair. Thus, we speculate that, in our system, fibroblasts supported the formation of microvessels by creating a physiological environment by matrix remodeling and by production and deposition of nonsoluble factors; however, . Blood and lymphatic capillaries are stably maintained in bioengineered human dermo-epidermal skin grafts. Grafts were transplanted onto six rats. (A) Hydrogel-based prevascularized dermo-epidermal skin grafts were generated using CD31 + HDMECs that form capillaries, CD90 + human dermal fibroblasts, and human K5 + keratinocytes (Z-stack confocal caption; digital surfacing; grid defines the 3D space). Scale bar, 50 mm. (B) The grafts were transplanted onto the backs of immunoincompetent nu/nu rats using a graft-protecting chamber. The dimensions of the bioengineered human skin are outlined in white. this has not been demonstrated yet. This dermal environment modulation by fibroblasts might explain why, in our 3D hydrogel system, capillary formation occurred in both fibrin and collagen type I hydrogels.
The lymphatic nature of the generated capillaries was confirmed by the expression of lineage-specific markers, as well as by morphology and function. Expression of Prox1-the most specific marker for lymphatic endothelium (15, 16)-Lyve-1, and podoplanin was detected in vitro and in vivo (37) . The presence of fibrillin-containing anchoring filaments was detected on the human lymphatics, suggesting that the bioengineered capillaries might react to interstitial pressure variations in vivo. Finally, Evans blue dye uptake and drainage assay preliminarily confirmed that the bioengineered lymphatic capillaries were functional in vitro and in vivo, respectively. The lymphangiogenic factors VEGF-C and VEGF-A increased the lymphatic vessel density, whereas Nuclei are stained with DAPI (blue). Confocal images are representative of n = 6 animals. Scale bars, 100 mm (A) (magnified view, 35 mm) and 50 mm (B) (magnified view, 25 mm). (C to E) Fifteen days after transplantation, Evans blue dye was intradermally injected into grafts of four animals containing either only fibroblasts (C) or bioengineered human capillaries (D) and imaged and quantified (E) after 30 minutes. P value was determined by Student's t test. Scale bars, 1 cm (C and D).
the addition of the lymphangiogenesis inhibitors TGF-b1 and SU5614 resulted in decreased capillary formation. These modulatory induction/ inhibition data, in addition to the possibility to retrieve the single cells from the hydrogels after vessel formation had occurred, qualify the 3D hydrogel system as a valuable in vitro model system and screening tool, well suited to identify signaling pathways, chemicals, and compounds involved in, or interfering with, human lymphatic vessel formation. In contrast to our system, most standard human lymphangiogenesis in vitro assays (38) , such as the tube formation (39) or spheroid assays (40) , are based on the evaluation of simple cord-like structures that only vaguely resemble the real morphology of bona fide lumen-forming human lymphatic capillaries.
When seeded in hydrogels, HDMECs, which consist of a mixture of hBECs and hLECs, spontaneously generated both a blood and a lymphatic vascular network, developing separately, yet adjacently in the same extracellular matrix. Although anastomoses between the two types of human vessels were never observed (8), the bioengineered human lymphatic capillaries were found to anastomose to the recipient rat's lymphatic plexus as early as 14 days after in vivo grafting. Human/rat lymphatic anastomosis occurred in either a direct connection or a wrapping connection manner. The "wrapping" anastomosis has been already described for blood vessels: The process includes matrix remodeling, pericyte removal, formation of a double-layered endothelium, and final maturation (41) . Because the bioengineered lymphatic capillaries exhibited an incomplete basement membrane and no mural cell coverage, and because our immunofluorescence analyses revealed an overlapping of human/rat signals on microvessels, we suggest that the anastomosis of lymphatic microvessels by the wrapping mechanism could be brought about by the generation of a double-layered endothelium before maturation.
Clearly, the effects of the incorporation of a lymphatic plexus into a dermo-epidermal graft on its regeneration after transplantation will have to be further investigated. To satisfy regulatory and safety aspects of translation, leading to approval of this advanced technology for clinical use, these grafts will need to be preclinically tested on an immunocompetent animal model, such as the pig, to investigate on safety, toxicology, and efficacy.
With respect to skin, it is possible to generate complex human skin grafts, encompassing a dermal and an epidermal equivalent (31), a melanocyte compartment (42) , and a plexus of blood and lymphatic capillaries (this study), whereas sweat glands, hair follicles, and neuronal innervation (43) have not yet been realized. Now, our study proposes a straightforward approach to engineer fully functional bona fide human lymphatic capillaries in hydrogel-based grafts, thus contributing to this broad spectrum of new possibilities in skin tissue engineering.
MATERIALS AND METHODS

Study design
The objective of this project was to engineer prevascularized dermoepidermal human skin grafts containing human blood and lymphatic capillaries. First, hLECs were cocultured with human dermal fibroblasts within 3D hydrogels to investigate the capacity of LECs to develop into lumen-forming bona fide lymphatic capillaries. HDMECs-rather than LECs-were then used to engineer prevascularized dermo-epidermal skin substitutes. HDMECs were chosen because they are a mixture of dermal blood and LECs; hence, these cells have the potential to give rise to both types of capillaries. Prevascularized skin grafts were engineered using either collagen type I or fibrin hydrogels, demonstrating that, principally, both types of biomatrices can be successfully used. However, we mainly used fibrin hydrogels because those present higher mechanical stability than collagen hydrogels. Collagen hydrogels were used for the cell reisolation experiments because they are more easily digested than fibrin hydrogels. The morphology and functionality of the lymphatic microvessels were characterized and analyzed both in vitro and in vivo with immunofluorescence, FACS, histology, and Evans blue dye injection.
Statisticians at the University of Zurich were consulted regarding sample size. Briefly, sample size calculations were performed with a confidence level of 95% and a statistical power of 70 to 80%. In vitro, the experimental end point was chosen at 21 days, when most of the engineered capillaries had formed a lumen. In vivo, the experimental end point was 15 days, when epidermal stratification was completed and a basal lamina was deposited. Physical damage of the hydrogels or premature death of the animals resulted in the exclusion from the study. No outlier was encountered in the quantitative analyses. Animals or hydrogels were always assigned randomly to the experimental groups. The experiments were not blinded, with the exception of experiments evaluating the response of the engineered capillaries to antilymphangiogenic stimuli (Fig. 3) . Three sample images were analyzed for each sample. All experiments were performed in triplicate.
Culture of hLECs hLECs were purchased from ScienceCell. Cells were cultured in endothelial basal medium (Cambrex) supplemented with 20% fetal bovine serum (Gibco), L-glutamine (2 mM, Fluka), hydrocortisone (10 mg/ml, Fluka), and N-6,2′-odibutyryladenosine-3′,5′-cyclic monophosphate sodium salt (cAMP; 25 mg/ml, Fluka) for up to five passages. Cells were grown in a humidified atmosphere at 37°C and 5% CO 2 . For the preparation of hydrogel matrices, cAMP was no longer added to the cultured medium, and endothelial cell supporting supplements (Cambrex) were added.
Isolation and culture of human dermal fibroblasts Dermal fibroblasts were isolated from human foreskins obtained from the University Children's Hospital of Zurich after routine circumcisions and stored in Dulbecco's modified Eagle's medium supplemented with gentamicin, penicillin-streptomycin, and fungizone (Invitrogen). All patients (n = 6) (and/or their parents) gave their written consent for this study in accordance with the Ethics Commission of the Kanton Zurich (notification no. StV-12=06).
Human foreskin biopsies were digested for 15 to 18 hours at 4°C in dispase (12 U/ml) in Hanks' balanced salt solution containing gentamicin (5 mg/ml). Thereafter, the epidermis and the dermis were mechanically separated. After collagenase treatment of the dermis, a total of 4 × 10 6 dermal cells per 10-cm dish were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum, 4 mM L-alanyl-L-glutamine, 1 mM sodium pyruvate, and gentamicin (5 mg/ml). Collagenase was from Sigma-Aldrich, and all other compounds were from Invitrogen.
Isolation and culture of HDMECs and dermal fibroblasts
HDMECs and human dermal fibroblasts were co-isolated from foreskins (n = 8) obtained from the University Children's Hospital of Zurich after routine circumcisions (Ethics Commission notification no. StV-12=06). Foreskins were processed as described earlier (7). Isolated HDMECs and fibroblasts were cocultured on 0.1% gelatin-coated dishes (SigmaAldrich) in endothelial cell growth medium-2 (EBM-2 MV with endothelial supplements; Lonza). Every day, fibroblasts were removed by mechanical scratching. FACS analysis for CD90 (Dianova) and CD31 (DakoCytomation) was used to calculate the number of fibroblasts and HDMEC (their ratio was 1:1 in all experiments). The cells were used at passage 1 in all experiments.
Generation of capillaries in hydrogels Fibrin or collagen hydrogels were produced with a Transwell system (7) consisting of six-well culture inserts with membranes with 3-mm pores (BD Falcon). Briefly, for fibrin hydrogels, fibrinogen from bovine plasma (Sigma-Aldrich) was reconstituted in NaCl to a final concentration of 10 mg/ml, and then 11 ml of thrombin (Sigma-Aldrich, 100 U/ml) was added. For collagen hydrogels, membranes were covered with rat tail collagen type I hydrogels (3.2 to 3.4 mg/ml, BD Biosciences). The collagen matrix was prepared as described (7, 44) . To 1 ml of hydrogel solution, either 60,000 hLECs in combination with 40,000 human dermal fibroblasts or 100,000 human dermal cells (HDMECs/fibroblasts, 1:1) were added and transferred into an insert for six-well plates. After clotting at room temperature, the preparations were incubated at 37°C for 35 min in a humidified incubator containing 5% CO 2 to ensure polymerization. At the end of the incubation period, culture medium was added to the upper and lower chambers [endothelial cell growth medium-2 (EBM-2 MV with endothelial supplements; Lonza)], and hydrogels were incubated for up to 3 weeks. Medium was changed every second day.
The role of fibroblasts in lymphatic vessel formation Fibrin hydrogels were produced as described above and cultured for 3 weeks in vitro. The hydrogels with 0 fibroblasts/100,000 LECs were cultured either in culture medium, in culture medium plus VEGF-A (40 ng/ml, Chemicon), in culture medium plus VEGF-C (100 ng/ml, R&D Systems), or in fibroblast-conditioned culture medium. The hydrogels with 10,000 fibroblasts/90,000 LECs or 40,000 fibroblasts/ 60,000 LECs were grown in culture medium. For the Transwell assay, 100,000 fibroblasts were seeded on the underside of the Transwell, whereas hydrogels with 100,000 LECs were cultured on top. The migration of a little number of fibroblasts was observed from the underside of the insert through the porous membrane intro the hydrogel. Culture medium was changed every day.
Validation of the lymphatic vessel formation in vitro assay Hydrogels were prepared as described above. At day 0, VEGF-A (40 ng/ml) (Chemicon), VEGF-C (100 ng/ml) (R&D Systems), TGF-b1 (10 ng/ml) (R&D Systems), 10 mM dimethyl sulfoxide (Sigma), and 1,3-dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2H-indol-2-one (SU5416, Sigma) were added to the culture medium. The medium was changed every second day. After 3 weeks, gels were fixed in 4% paraformaldehyde (PFA) and processed for whole-mount immunostainings. Control culture medium was composed of endothelial basal medium (Cambrex) supplemented with 20% fetal bovine serum (Gibco), L-glutamine (2 mM, Fluka), and hydrocortisone (10 mg/ml, Fluka).
Isolation of single-cell suspensions from hydrogels containing lymphatic capillaries At day 21, collagen type I hydrogels were incubated in a solution of collagenase type 2/DMEM (35 U/ml, Worthington Lakewood) for 1 hour at 37°C. After the incubation, single cells were collected by the use of cell strainers (0.40 mm, BD Pharmingen), centrifuged, counted, and prepared for FACS sorting (FACSAria III cell sorter, BD Biosciences). CD31 + /CD90
− hLECs and CD31 − /CD90 + human fibroblasts were sorted. The antibodies used were the following: mouse anti-human prelabeled CD31-phycoerythrin (DakoCytomation, 1:50) and monoclonal mouse anti-human prelabeled CD90-fluorescein isothiocyanate (Dianova, 1:10). Finally, the two cell populations were submerged again in gelifying collagen type I to test for the capability to develop into lymphatic capillaries.
Preparation of prevascularized skin grafts After 2 weeks of culture, 1 million human keratinocytes, isolated as described (31) , were seeded on top of the prevascularized fibrin hydrogels. One week thereafter, transplantation or whole-mount immunostaining was performed.
2D tube formation assay
Tube formation assays were performed as previously described (45) . Briefly, a confluent hLEC monolayer was overlaid with collagen type I hydrogels (1 mg/ml; Cohesion). Tube-like structure formation was evaluated after 20 hours.
Evans blue fluid uptake in vitro assay A solution of Evans blue (25 mg/ml) (Sigma-Aldrich) was prepared in phosphate-buffered saline (PBS). A total of 20 to 80 ml (focal injections of 20 ml) of this solution was laterally injected into a hydrogel with an insulin syringe (0.30 × 12 mm 2 ). After 20 min, hydrogels were analyzed under bright light. To remove excess dye, one washing step with PBS/0.3% Triton X overnight at room temperature and constant shaking were performed before the whole-mount immunofluorescence staining.
Grafting bioengineered skin grafts onto immunoincompetent nu/nu rats Animal studies were performed with the approval of the Institutional Animal Care of the University of Zurich following the guidelines of the National Institutes of Health. Immunoincompetent female nu/nu rats (Elevage Janvier) (n = 12) were anesthetized by inhalation of 5% isoflurane (Baxter) and narcosis maintained by inhalation of 2.5% isoflurane via mask. Before the operation, buprenorphine (0.5 mg/kg) (Temgesic) for analgesia and retinol cream (Vitamin A "Blache"; Bausch & Lomb) for eye protection were applied. To prevent wound closure from the side and overgrowth of the human transplant by rat tissue, a special polypropylene ring (modified Fusenig chamber), 2.6 cm in diameter, was designed in our laboratory. The rings were sutured to full-thickness skin defects created on the back of the rats with nonabsorbable polyester sutures (Ethibond; Ethicon). Cultured prevascularized dermo-epidermal skin grafts were placed into the polypropylene rings and covered with a silicon foil (Silon-SES; Bio Med Sciences) and polyurethane sponges (Ligasano; Ligamed). Rats were sacrificed at 15 days after surgery. At sacrifice, dressings and sutures were removed, and multiple graft biopsies (n = 12) were collected for different analyses.
In vivo lymphatic drainage assessment with Evans blue dye Fifteen days after transplantation on the rats, 25 ml of Evans blue dye (10 mg/ml in PBS, Sigma-Aldrich) was injected with a Hamilton syringe into hydrogel-based grafts. Thirty minutes later, pictures of the grafts were taken. Subsequently, animals were sacrificed, and the Evans blue dye was extracted from the graft by incubation for 3 days in formamide (Fluka) at room temperature. The background-subtracted absorbance was measured on an Epoch microplate reader (Bio-Tek) by measuring the wavelength at 620 and 740 nm. The concentration of dye in the extracts was calculated with a standard curve of Evans blue in formamide.
Immunofluorescence stainings and quantifications Hydrogel matrices were collected and fixed in 4% PFA for 6 hours at room temperature and processed for either whole-mount immunostainings or paraffin/cryo embedding and cutting.
For whole-mount immunostainings, samples were blocked with 10% bovine serum albumin (Sigma-Aldrich) and 0.3% Triton X (SigmaAldrich) in PBS. Primary and secondary antibodies were applied overnight at room temperature. Washing steps were performed with PBS and 0.3% Triton X. For paraffin preparations, samples were dehydrated and mounted in paraffin wax. For cryosections, samples were frozen in OCT compound (Tissue-Tek). Cross-sections (10 or 40 mm) were cut and mounted on glass slides. For all immunofluorescence procedures, the following primary antibodies were used: rabbit antihuman Prox1 (Reliatech; 1:300), monoclonal mouse anti-human CD31 (DakoCytomation; 1:50), monoclonal mouse anti-human CD90 (Dianova; 1:10), rabbit anti-human Lyve-1 (Abcam; 1:100), mouse anti-human podoplanin (Santa Cruz Biotechnology, 1:50), mouse anti-human aSMA (DakoCytomation), mouse anti-rat podoplanin (Reliatech), mouse anti-human collagen IV (Abcam), mouse anti-human fibrillin (Millipore), and mouse anti-human laminin 1+2 (Abcam). Corresponding secondary antibodies were labeled with Alexa Fluor 488 or 594 (Molecular Probes). Cell nuclei were counterstained with Hoechst bisbenzimide (Sigma-Aldrich). Stained specimens were examined with a Nikon Eclipse TE-2000-U confocal microscope. Adobe Photoshop CS3 (Adobe Systems) was used for image overlay. The Imaris software (Bitplane AG) was used to create 3D pictures (Z-stack) and digital surface images of confocal data. Computer-assisted morphometric vessel analyses were performed with Adobe Photoshop CS3. The average vessel area and vessel number per group were calculated, and statistical analysis was performed with GraphPad Prism (GraphPad Software Inc.).
Statistical analysis
The statistical analysis was carried out with the software GraphPad Prism. Student's t test, paired, two-tailed, with 95% confidence interval, without adjustments to a levels, was used for all comparisons. P < 0.05 was considered significant. Data are shown as means ± SEM.
